Search - tctmd.com

Displaying 1 - 20 of 159

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

TCT 1285: Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): 5-year follow-up of a randomized controlled trial

Presenter: Lei Song

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

Presentation TCT 2025

TCT 408: Quantitative Flow Ratio-Guided Percutaneous Coronary Intervention Stratified by Coronary Territories: a Prespecified Subgroup Analysis of the FAVOR III China Trial

Presenter: Lei Song

October 26, 2025

Presentation TCT 2025

Recent Coronary Trials: Role of Physiology - Put the Brakes On! (FAME 3; FAVOR 3; FLOWER MI)

Presenter: Kyung Woo Park

October 26, 2025

Presentation TCT 2025

QFR vs. FFR for Coronary Revascularization Guidance: 2-Year Follow-up of the FAVOR III Europe Trial

Presenter: Birgitte Krogsgaard Andersen

October 25, 2025

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

Presentation TCT 2024

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

Presenter: han zhang

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

Presenter: Hao-Yu Wang

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

TCT 1285: Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): 5-year follow-up of a randomized controlled trial

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

TCT 408: Quantitative Flow Ratio-Guided Percutaneous Coronary Intervention Stratified by Coronary Territories: a Prespecified Subgroup Analysis of the FAVOR III China Trial

Recent Coronary Trials: Role of Physiology - Put the Brakes On! (FAME 3; FAVOR 3; FLOWER MI)

QFR vs. FFR for Coronary Revascularization Guidance: 2-Year Follow-up of the FAVOR III Europe Trial

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content